What Is The Fitc Dextran Permeability Assay?

The FITC dextran permeability assay is a laboratory test that measures how easily a fluorescent molecule called FITC dextran passes through a layer of cells. It is used to study barrier function in the gut, blood vessels, and other tissues. The test works because FITC dextran glows under specific light, allowing researchers to track its movement precisely.

What Is The FITC Dextran Permeability Assay?

The assay uses a molecule made of dextran, a type of sugar, chemically linked to a fluorescent dye called FITC. When this molecule crosses a cell barrier, researchers can detect it by measuring the fluorescence in the fluid on the other side. This measurement tells them how permeable the barrier was during the experiment.

Think of it as a tracer test. A known amount of FITC dextran is placed on one side of a cell layer. After a set time, samples are taken from the other side. The amount of fluorescence in those samples directly reflects how much FITC dextran crossed the barrier. More fluorescence means a more open or damaged barrier.

How Does the FITC Dextran Assay Work in Practice?

Researchers use this assay in two main ways: in cell culture dishes and in live animals. Both approaches follow the same basic principle but differ in their details.

In cell culture, cells are grown on a porous membrane inside a small plastic insert. The insert sits in a well containing culture medium. FITC dextran is added to the top chamber. After incubation, the medium in the bottom chamber is collected and read on a fluorescence plate reader. This setup is common for testing how drugs or inflammatory molecules affect a cell barrier.

In live animals, typically mice, the procedure is different. The animal is given FITC dextran by mouth using a feeding tube. After a few hours, a blood sample is taken. If the gut barrier is healthy, very little FITC dextran enters the bloodstream. If the barrier is damaged, more of it leaks through the intestinal wall and appears in the blood. This version of the assay is widely used in studies of intestinal diseases like inflammatory bowel disease.

What Does the FITC Dextran Assay Measure Exactly?

The assay measures paracellular permeability. That means it tracks movement between cells, not through them. Cells in a healthy barrier are connected by tight junctions, which are protein complexes that seal the space between neighboring cells. When these junctions break down, the space opens up and larger molecules can pass through.

FITC dextran comes in different molecular weights. The most common sizes are 4 kDa and 70 kDa. Smaller dextran molecules cross more easily than larger ones. This allows researchers to estimate the size of the gaps in a damaged barrier. A barrier that lets 70 kDa FITC dextran through is more severely damaged than one that only lets 4 kDa through.

It is important to note that this assay only measures one type of permeability. It does not measure transcellular transport, which is movement through the cells themselves. It also does not tell you why the barrier is leaky. It only tells you that it is leaky and to what degree.

Why Is the FITC Dextran Assay Useful in Research?

The assay is valued because it is quantitative and reproducible. The results are numerical, not subjective. This makes it easy to compare data across experiments or between different research groups.

It is also relatively simple to perform. The materials are commercially available, and the readout requires only a fluorescence plate reader. This accessibility has made it a standard tool in laboratories studying barrier function.

Research using this assay has contributed to understanding conditions where barrier breakdown is thought to play a role. These include celiac disease, Crohn’s disease, ulcerative colitis, and some food allergies. It is also used in studies of the blood-brain barrier, though less commonly than in gut research.

The assay has limitations that researchers must consider. FITC dextran is not a natural molecule, so its behavior may not perfectly represent how real proteins or nutrients cross a barrier. Also, results can vary based on the cell type used, the passage number of the cells, and the specific protocol followed. These factors make it hard to compare absolute numbers between different laboratories, even when the relative results within a single experiment are reliable.

How Do Researchers Analyze FITC Dextran Results?

The raw data from the assay is fluorescence intensity, usually expressed as relative fluorescence units or RFUs. To make this data meaningful, researchers often create a standard curve using known concentrations of FITC dextran. This curve converts fluorescence readings into actual concentrations.

From there, results are often expressed as apparent permeability, sometimes written as Papp. This value accounts for the surface area of the membrane and the time of the experiment. It allows for comparison across different experimental setups.

In animal studies, results are typically reported as the concentration of FITC dextran in the blood serum. Higher serum concentrations indicate greater intestinal permeability. Some studies also calculate the ratio of FITC dextran in blood to the amount given, which normalizes for differences in dosing.

One common mistake in interpreting this assay is assuming that a single time point tells the whole story. Permeability can change over time. Measuring at multiple time points gives a more complete picture of how a barrier responds to a treatment or injury.

What Are the Alternatives to the FITC Dextran Assay?

The FITC dextran assay is not the only way to measure barrier function. Several other methods exist, each with its own strengths and weaknesses.

One common alternative is measuring transepithelial electrical resistance, often called TEER. This technique uses electrodes to measure the electrical resistance across a cell layer. A healthy barrier has high resistance because it blocks the flow of ions. When the barrier is damaged, resistance drops. TEER is non-invasive and can be measured repeatedly on the same cells, but it only reflects ion movement, not the passage of larger molecules.

Another approach uses radioactively labeled molecules, such as 51Cr-EDTA. This method is sensitive but requires special handling due to radioactivity. It is used less often now because of safety and disposal concerns.

Some researchers use fluorescently labeled proteins or other biologically relevant molecules instead of dextran. These can provide more physiologically meaningful data, but they are harder to work with because proteins may be degraded or actively transported.

In clinical settings, tests like the lactulose-mannitol ratio are used to assess gut permeability in humans. This test involves drinking a solution containing both sugars and measuring how much appears in the urine. It is non-invasive and has been used for decades, but it is less precise than the FITC dextran assay and is not suitable for animal studies.

What Are the Limitations of the FITC Dextran Assay?

No assay is perfect, and the FITC dextran method has several known limitations that researchers must keep in mind.

First, FITC dextran is pH-sensitive. The fluorescence signal can change if the pH of the sample is not consistent. This is rarely a problem in controlled laboratory conditions, but it can introduce variability if samples are handled differently.

Second, the assay does not distinguish between different routes of transport. If a molecule crosses a barrier both between cells and through cells, the assay will measure the total amount without separating the two pathways. This can be misleading if a treatment affects only one route.

Third, the size of the FITC dextran molecule matters. A 4 kDa dextran is roughly the size of a small protein, while a 70 kDa dextran is closer to the size of albumin. Choosing the wrong size for a research question can lead to incorrect conclusions about barrier integrity.

Fourth, in animal studies, the timing of blood collection is critical. If blood is drawn too early or too late, the results may not reflect peak permeability. Most protocols call for blood collection four hours after oral administration, but this timing may need adjustment depending on the specific research question.

Finally, the assay measures permeability at a single point in time. It does not capture dynamic changes that occur over hours or days. For studies of chronic conditions, repeated measurements or additional methods may be necessary.